Page last updated: 2024-09-03

4-nitrophenyl myo-inositol-1-phosphate and n-nitrosopiperidine

4-nitrophenyl myo-inositol-1-phosphate has been researched along with n-nitrosopiperidine in 2 studies

Compound Research Comparison

Studies
(4-nitrophenyl myo-inositol-1-phosphate)
Trials
(4-nitrophenyl myo-inositol-1-phosphate)
Recent Studies (post-2010)
(4-nitrophenyl myo-inositol-1-phosphate)
Studies
(n-nitrosopiperidine)
Trials
(n-nitrosopiperidine)
Recent Studies (post-2010) (n-nitrosopiperidine)
702103018

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Lin, K; Lu, S; Shen, W; Shen, Z; Wu, Y1
Cai, L; Cai, X; Liao, L; Lin, S; Shen, M; Su, Y; Wang, H1

Other Studies

2 other study(ies) available for 4-nitrophenyl myo-inositol-1-phosphate and n-nitrosopiperidine

ArticleYear
Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China.
    International journal of cancer, 2002, Nov-20, Volume: 102, Issue:3

    Topics: Adult; Carboxylic Acids; China; Diet; Diethylnitrosamine; Dimethylnitrosamine; Esophageal Neoplasms; Humans; Inositol Phosphates; Male; Middle Aged; N-Nitrosopyrrolidine; Nitrosamines; Nitroso Compounds; Thiazoles; Thiazolidines

2002
Characteristics and health risk assessment of volatile N-nitrosamines in the plasma of adults in Guangdong Province, China.
    Journal of pharmaceutical and biomedical analysis, 2023, Apr-01, Volume: 227

    Topics: Adult; China; Humans; Nitrosamines; Reproducibility of Results; Risk Assessment

2023